Skip to main content

Peer Review reports

From: IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation

Original Submission
24 Jul 2022 Submitted Original manuscript
1 Sep 2022 Author responded Author comments - Taigo Kato
Resubmission - Version 2
1 Sep 2022 Submitted Manuscript version 2
Publishing
3 Dec 2022 Editorially accepted
9 Dec 2022 Article published 10.1186/s12885-022-10398-6

You can find further information about peer review here.

Back to article page